cbdMD, Inc.

US$0.42As of Sun 8 Nov 2026, 12:00 UTC
AMEX:YCBDHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (63.38%)
Div yield —
ROE (40.33%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 2.37
PE TTM —
TSR TTM (52.43%)
Mkt cap US$4.661M
ROIC (20.74%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.52
24.94%
(28.29%)
Hold 5|10|7|9|9
1Q26
2Q26
3Q26
4Q26
Earnings per share$
—
—
—
—
13.69%
12.59%
13.63%
18.24%
Revenue$M
0.300
0.301
0.296
0.293
0.89%
(1.07%)
(4.12%)
(3.31%)
Peers (US$4.661M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.988
0.101
0.077
EBIT/Intx
1.019
0.096
0.111
Own earn%
15.40
(256.97)
(169.25)
Sh yield%
42.29
5.71
6.78
Owners
Insiders/Inst%
6.58
86.06
Short interest%
3.80
SBC / revenue%
0.61
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
25–28
$1 testx
0.0
Incr. ROIC%
11